Refer to Case Study 21.1, illustrating the role of calcium in reducing the symptoms of PMS. Using the caution given at the end of the case study, explain why we cannot use the method presented in Section 21.2 to compare baseline symptom scores with third-cycle symptom scores for the calcium-treated group alone.